1Y Annualised Return
▲96.63%
3Y Annualised Return
▲36.94%
Acutaas Chemicals Stock Performance
|
|
|
Acutaas Chemicals Company background
Ami Organics Limited was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of Ami Organics Private Limited with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, following which the Companys name was changed to Ami Organics Limited, and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018.The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011 it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 5050 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure a storage capacity of 1,050 MT of RM in 2017.The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021. The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021. The Company incorporated wholly owned subsidiary Ami Organics Electrolytes Private Limited in 2023. The Company further embarked on setting brownfield project at Ankleshwar entailing a capex of Rs. 1900 Million. The existing Ankleshwar facility was demolished and work started to set up a new plant with advance technology for pharma intermediates business, scheduled to have installed capacity of 436.5 KL.The Company acquired a 55% stake in Baba Fine Chemicals (BFC) in FY 2024. A stateoftheart technology driven plant in Ankleshwar Unit with the total reactor capacity of 442 KL dedicated for manufacture of advanced pharmaceutical intermediate business was established.
Acutaas Chemicals Financial Highlights
Acutaas Chemicals reported a Q2 FY2025–2026 revenue of ₹207.24 crore, up 41.2% YoY, with net profit increased 229.3% to ₹44.01 crore. For the full year FY2025–2026, revenue reached ₹1023.8 crore and profit touched at ₹160.42 crore. As of Jun '25, Acutaas Chemicals ’s market capitalisation stood at ₹10,867.28 crores. Shareholding as of Jun '25 shows promoters holding 32.7%, with FIIs at 16.9%, DIIs at 22.4%, and public at 28%.
As of , Acutaas Chemicals share price is ₹1327.4. The stock opened at ₹1177.3 and had closed at ₹1220.3 the previous day. During today’s trading session, Acutaas Chemicals share price moved between ₹1,171.20 and ₹1,350.00, with an average price for the day of ₹1260.60. Over the last 52 weeks, the stock has recorded a low of ₹607.50 and a high of ₹1,350.00. In terms of performance, Acutaas Chemicals share price has increased by 12.6% over the past six months and has increased by 96.63% over the last year.
Over the past
Acutaas Chemicals Fundamental
Market Cap (in crs)
10,867.28
Face Value
5
Turnover (in lacs)
27,898.47
Key Metrics
Acutaas Chemicals Key Financials
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
207.24 Cr | 308.48 Cr | 274.99 Cr | 246.73 Cr | 176.67 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
1023.8 Cr | 724.97 Cr | 621.05 Cr | 522.9 Cr | 341.99 Cr | 242.49 Cr |
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
44.01 Cr | 62.72 Cr | 45.45 Cr | 37.57 Cr | 14.69 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | 54 Cr | 27.47 Cr |
Acutaas Chemicals Result Highlights
Result Summary
-
Acutaas Chemicals Ltd reported a 1.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 25.6%.
-
Its expenses for the quarter were down by 12.5% QoQ and up 4.7% YoY.
-
The net profit increased 71.4% QoQ and increased 199.6% YoY.
-
The earnings per share (EPS) of Acutaas Chemicals Ltd stood at 5.4 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Acutaas Chemicals Technical Analysis
Moving Averages Analysis
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 794288 Rs | 2199460 Rs |
Week Rs | 287475 Rs | 744139 Rs |
Month Rs | 191095 Rs | 388347 Rs |
Resistance & Support
Acutaas Chemicals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 11,523.15 | 422 | 721 | 492.15 | 1.24% | -2.91% | -15.96% | -24.80% | 56.06% | 0.32% | 38.74 | 41.68 | 3.39 | |
- | 10,307.21 | 171 | 358.7 | 236.25 | -0.13% | -12.01% | -7.54% | 10.62% | 365.13% | 0.35% | 55.02 | 41.68 | 7.46 | |
- | 9,786.17 | 4863 | 6175.5 | 5,947.00 | 1.46% | 1.25% | 9.30% | 11.19% | 34.48% | 4.41% | 37.66 | 41.68 | 18.24 | |
- | 8,686.28 | 555 | 1000 | 919.15 | -2.41% | 1.49% | 27.71% | 29.07% | 113.50% | 0.11% | 90.54 | 41.68 | 3.20 | |
- | 12,644.29 | 850 | 1335.1 | 1,050.30 | 0.26% | 3.26% | -10.73% | 14.22% | 117.46% | 0.48% | 26.02 | 41.68 | 4.48 | |
- | 11,303.43 | 4211.55 | 5894.5 | 4,959.00 | -1.40% | -9.46% | 3.01% | 0.00% | 0.00% | 1.12% | 60.28 | 41.68 | 41.38 |
Acutaas Chemicals Share Price FAQs
How has Acutaas Chemicals shares performed in the past ?
Acutaas Chemicals share price in the past 1-year return was 96.62. The Acutaas Chemicals share hit a 1-year low of Rs. 607.5 and a 1-year high of Rs. 1350.
What is the market cap of Acutaas Chemicals ?
The market cap of Acutaas Chemicals is Rs. 10867.28 Cr. as of 31/7/2025.
What is the current P/E ratio of Acutaas Chemicals ?
The PE ratios of Acutaas Chemicals is 57.12 as of 31/7/2025.
What is the current PB ratio of Acutaas Chemicals ?
The PB ratios of Acutaas Chemicals is 8.29 as of 31/7/2025
What is the Mutual Fund shareholding in Acutaas Chemicals ?
The Mutual Fund Shareholding in Acutaas Chemicals was 16.27% at the end of 31/7/2025.
How to buy Acutaas Chemicals shares?
You can easily buy Acutaas Chemicals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Acutaas Chemicals ?
The 52-week high and low of Acutaas Chemicals share price is ₹1350 and ₹607.5 as of 31/7/2025.
What is the EPS of Acutaas Chemicals ?
The earnings per share (EPS) of Acutaas Chemicals stood at 5.4 during Q1 FY 2025-26.
Please be aware that Acutaas Chemicals stock prices are subject to continuous fluctuations due to various factors.